SCHEMBL6447761

SCHEMBL6447761

OCCC1OC(n2cnc3c(SCc4ccc5nsc(Br)c5c4)ncnc32)C(O)C1O

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SLC29A1 Q99808 19/20 0.62
▸ STAT6 P42226 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5040214 0.94 SLC29A1 (0.71) SLC29A1STAT6
SCHEMBL6288483 0.88 SLC29A1 (0.63) SLC29A1STAT6
SCHEMBL6447906 0.82 SLC29A1 (0.46) SLC29A1STAT6
SCHEMBL5040226 0.78 SLC29A1 (0.70) SLC29A1STAT6
SCHEMBL5037089 0.77 SLC29A1 (0.75) SLC29A1STAT6
SCHEMBL5040551 0.77 SLC29A1 (0.71) SLC29A1STAT6
SCHEMBL5042140 0.77 SLC29A1 (0.71) SLC29A1STAT6
SCHEMBL5044746 0.75 SLC29A1 (0.71) SLC29A1STAT6
SCHEMBL5044754 0.75 SLC29A1 (0.71) SLC29A1STAT6
6-Benzylthioinosine SCHEMBL15427008 0.73 SLC29A1 (1.00) SLC29A1STAT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608377-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS Affinium Pharmaceuticals, Inc. (CA) 2005-12-28 — — EP disclosed
WO-2004082586-A2 PHAMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF FAB I AND FURTHER ANTIBIOTICS AFFINIUM PHARMACEUTICALS, INC. (US) 2004-09-30 — — WO disclosed
Send feedback